Generali, Daniele
 Distribuzione geografica
Continente #
NA - Nord America 228
EU - Europa 176
AS - Asia 49
AF - Africa 13
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 1
Totale 469
Nazione #
US - Stati Uniti d'America 227
SE - Svezia 62
IT - Italia 35
IE - Irlanda 31
SG - Singapore 21
CI - Costa d'Avorio 13
RU - Federazione Russa 13
IN - India 11
CN - Cina 9
DE - Germania 7
GB - Regno Unito 7
FR - Francia 6
ES - Italia 4
KR - Corea 4
NL - Olanda 3
BE - Belgio 2
FI - Finlandia 2
HK - Hong Kong 2
HU - Ungheria 2
TR - Turchia 2
A1 - Anonimo 1
AT - Austria 1
BR - Brasile 1
CA - Canada 1
CZ - Repubblica Ceca 1
EU - Europa 1
Totale 469
Città #
Chandler 79
Dublin 31
Ashburn 18
Abidjan 13
Moscow 13
Boston 12
Milan 12
Princeton 12
New York 10
Pune 10
Singapore 9
Montepulciano 4
Seoul 4
Amsterdam 3
Ann Arbor 3
Los Angeles 3
Majadahonda 3
Marseille 3
Munich 3
San Mateo 3
Ankara 2
Boardman 2
Bremen 2
Brescia 2
Brussels 2
Budapest 2
Busto Arsizio 2
Campi Bisenzio 2
Chiswick 2
Hong Kong 2
London 2
Naples 2
Nova Milanese 2
Paris 2
Rome 2
Seattle 2
Seveso 2
Shanghai 2
Andover 1
Augusta 1
Beijing 1
Brno 1
Clearwater 1
Council Bluffs 1
Fisciano 1
Frankfurt am Main 1
Helsinki 1
Kilburn 1
Lappeenranta 1
Madrid 1
Milpitas 1
Mumbai 1
New Bedfont 1
Redmond 1
Rochester 1
São Paulo 1
Toronto 1
Vienna 1
Wilmington 1
Woodbridge 1
Zhengzhou 1
Totale 307
Nome #
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence 71
Patients’ Engagement in Early Detection of COVID-19 Symptoms: An Observational Study in the Very Early Peak of the Pandemic in Italy in 2020 40
A network meta-analysis of everolimus plus exemestane versus chemotherapy in the first- and second-line treatment of estrogen receptor-positive metastatic breast cancer 32
Hypoxia-related biological markers as predictors of epirubicin- based treatment responsiveness and resistance in locally advanced breast cancer 31
Overall survival of CDK4/6-inhibitors-based treatments in clinically relevant subgroups of metastatic breast cancer: systematic review and meta-analysis 31
BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-Making 29
New omics information for clinical trial utility in the primary setting 27
Role of targeted agents in neuroendocrine tumours: results from a meta-analysis 25
Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancer 24
Pure anti-tumor effect of zoledronic acid in naïve bone-only metastatic and locally advanced breast cancer: proof from the "biological window therapy" 23
Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis 23
Faecal microbiota composition is related to response to CDK4/6-inhibitors in metastatic breast cancer: A prospective cross-sectional exploratory study 22
Response rate as a potential surrogate for survival and efficacy in patients treated with novel immune checkpoint inhibitors: a meta-regression of randomised prospective studies 22
Anthracyclines strike back: Rediscovering non‐pegylated liposomal doxorubicin in current therapeutic scenarios of breast cancer 21
Multiple Bayesian network meta-analyses to establish therapeutic algorithms for metastatic triple negative breast cancer 21
Seroconversion in patients with cancer and oncology healthcare workers infected by SARS-CoV-2 21
Canakinumab as treatment for COVID-19-related pneumonia: A prospective case-control study 17
Endocrine‐based treatments in clinically‐relevant subgroups of hormone receptor‐positive/her2‐negative metastatic breast cancer: Systematic review and meta‐analysis 9
Totale 489
Categoria #
all - tutte 4.409
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.409


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 1 0 0 1 1 0
2021/202260 0 0 2 2 4 1 1 4 4 1 18 23
2022/2023218 19 33 14 18 26 26 18 20 28 2 3 11
2023/2024196 7 53 9 9 15 20 14 14 3 14 24 14
2024/202512 12 0 0 0 0 0 0 0 0 0 0 0
Totale 489